SAINT GOBAIN 85.440 € (+0,85 %) AMUNDI 96.750 € (-0,36 %) SANOFI 75.310 € (+1,35 %) COFACE 16.100 € (-0,19 %) 
TOMTOM 4.042 € (+1,56 %) 
X-FAB 7.030 € (+3,84 %) 
MAROC TELECOM 9.000 € (+0,22 %) UMG 15.565 € (+2,71 %) SOITEC 122.500 € (+1,45 %) PHILIPS KON 23.130 € (+0,70 %) 
UNILEVER 54.650 € (-0,78 %) ATOS GROUP 31.700 € (-0,13 %) CARVOLIX 6.200 € (-1,90 %) ENERGY SOLAR 1.400 € (+1,08 %) MEDINCELL 24.500 € (-1,69 %) AALBERTS NV 45.080 € (+0,54 %) L'OREAL 385.900 € (-1,15 %) S.E.B. 59.500 € (-0,67 %) LUMIBIRD 27.000 € (+1,50 %) BONDUELLE 8.610 € (-1,37 %) ADYEN 930.300 € (-0,31 %) PEUGEOT INVEST 57.500 € (+0,35 %) LAKEFRONT BIOTHER. 23.340 € (+3,83 %) LVMH 480.000 € (-0,30 %) ENGIE 26.720 € (+0,60 %) CSG 17.714 € (-8,02 %) ABN AMRO BANK N.V. 39.730 € (-0,13 %) SBM OFFSHORE 32.400 € (-7,69 %) BUREAU VERITAS 28.360 € (-0,28 %) AB SCIENCE 1.000 € (+24,07 %) KERING 286.650 € (-1,07 %) BOUYGUES 48.640 € (-1,12 %) AKZO NOBEL 63.520 € (-0,06 %) NANOBIOTIX 33.460 € (+0,78 %) HEINEKEN 77.140 € (-0,87 %) ALTAREA 100.400 € (-0,20 %) REMY COINTREAU 46.600 € (+2,69 %) RUBIS 33.400 € (+0,30 %) KAUFMAN ET BROAD 25.250 € (+0,60 %) TELEPERFORMANCE 70.000 € (+1,92 %) HAFFNER ENERGY 0.456 € (-1,19 %) SHELL PLC 38.390 € (-1,01 %) 2CRSI 27.600 € (-0,79 %) TIKEHAU CAPITAL 17.020 € (+0,59 %) V LANSCHOT KEMPEN 65.250 € (-0,76 %) TRIGANO 152.900 € (+1,12 %) LISI 67.200 € (+1,66 %) HEINEKEN HOLDING 72.650 € (-1,29 %) Coca-ColaEuropacif 92.900 € (-1,06 %) UNIFY GROUP 1.862 € (-0,53 %) POSTNL 0.911 € (-2,57 %) ASML HOLDING 1 499.000 € (+0,33 %) PHARMING GROUP 0.960 € (+1,52 %) EXAIL TECHNOLOGIES 124.600 € (+0,08 %) VETOQUINOL 72.600 € (+1,82 %) CTP 14.680 € (-3,17 %) TOTALENERGIES 74.090 € (-0,60 %) CROSSJECT 1.498 € (-1,45 %) VEOLIA ENVIRON. 35.190 € (+0,34 %) RELX 30.840 € (+1,05 %) |
07/08/2026 17:45
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capitalMonthly information regarding the total number of voting rights and shares comprising the share capitalArticle L233-8-II of the Commercial CodeArticle 223-16 of the General Regulations of the AMFParis, August 7th, 2026, Listing: Euronext Growth Paris
(1) The gross number of voting rights (or "theoretical" voting rights) serves as the basis for calculating the thresholds. In accordance with Article 223-11 of the General Regulations of the AMF, this number is calculated on the basis of all shares carrying voting rights, including shares without voting rights. (2) The net number of voting rights (or voting rights "exercisable in General Meeting") is calculated without considering the shares with suspended voting rights. It is published for proper public information in accordance with the AMF recommendation of July 17, 2007. *** About Mauna Kea TechnologiesMauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time, assess point-in-time reactions as they happen in real time, classify indeterminate areas of concern, and guide surgical interventions. The Cellvizio® platform is used globally across a wide range of medical specialties and is making a transformative change in the way physicians diagnose and treat patients. For more information, visit www.maunakeatech.com. Mauna Kea Technologies NewCap - Investor Relations Source : Webdisclosure.com |
||||||||||||
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière